Schwarz Esther I, Ramach Constanze, Mende Katja A, Strobel Klaus
Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland.
Clin Nucl Med. 2009 Apr;34(4):249-50. doi: 10.1097/RLU.0b013e31819a208f.
F-18 fluorodeoxyglucose (FDG)-PET-CT is increasingly used in the management of patients with ovarian cancer. However, there is a considerable overlap in the imaging features of malignant and benign ovarian lesions because physiological FDG-uptake in the ovaries can occur, depending on the menstrual cycle in premenopausal women.We present a case of FDG uptake in the ovary co-occurring with an intensely FDG active tumor of the abdominal wall in a 44-year-old woman. PET-CT findings, together with medical history, raised the suspicion for a metastasizing ovarian cancer. However, histologic examination demonstrated benign findings, namely abdominal wall leiomyoma and an ovarian follicular cyst.
F-18氟脱氧葡萄糖（FDG）-PET-CT在卵巢癌患者的管理中应用越来越广泛。然而，恶性和良性卵巢病变的影像学特征存在相当大的重叠，因为卵巢的生理性FDG摄取可能会发生，这取决于绝经前女性的月经周期。我们报告一例44岁女性，其卵巢出现FDG摄取，同时腹壁有一个FDG摄取强烈的肿瘤。PET-CT检查结果结合病史，引发了转移性卵巢癌的怀疑。然而，组织学检查显示为良性结果，即腹壁平滑肌瘤和卵巢滤泡囊肿。
